Precision dosing
Showing 1 - 25 of 6,708
Informed preciSion doSIng tO iNdividualise and Optimize
Not yet recruiting
- Pharmacokinetics
- +4 more
- venipuncture
- (no location specified)
Oct 16, 2023
Type 2 Diabetes Trial in San Francisco (Metformin)
Not yet recruiting
- Type 2 Diabetes
-
San Francisco, CaliforniaUCSF Madison Clinic for Pediatric Diabetes
Nov 1, 2023
Vancomycin Trial in Brugge, Ghent (Vancomycin model-informed precision dosing, Vancomycin)
Recruiting
- Vancomycin
- Vancomycin model-informed precision dosing
- Vancomycin
-
Brugge, Belgium
- +1 more
Sep 7, 2022
Physical Inactivity, Weight Gain Trial (Education, Activity tracker, Text messaging (random timing and selection))
Not yet recruiting
- Physical Inactivity
- Weight Gain
- Education
- +3 more
- (no location specified)
Mar 20, 2023
Teicoplanin in Intensive Care and Haematology Patients
Completed
- Bacterial Infections
- No intervention
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Jan 30, 2023
Allogeneic Hematopoietic Cell Transplantation Trial (Alemtuzumab)
Not yet recruiting
- Allogeneic Hematopoietic Cell Transplantation
- (no location specified)
Aug 12, 2022
Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Autologous Hematopoietic Stem Cell
Recruiting
- Hematopoietic Stem Cell Transplantation
- +2 more
- GSTA1 genotyping
-
Geneva, SwitzerlandHôpitaux Universitaires de Genève
Jul 30, 2021
Liver Transplant, Kidney Transplant Trial in Los Angeles, Gainesville, Singapore (PPM-based Computation Assisted Drug Dosing,
Completed
- Liver Transplant
- Kidney Transplant
- PPM-based Computation Assisted Drug Dosing
- Tacrolimus
-
Los Angeles, California
- +2 more
Dec 9, 2021
Allogeneic Hematopoietic Cell Transplantation Trial in Cincinnati (Alemtuzumab)
Completed
- Allogeneic Hematopoietic Cell Transplantation
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 3, 2019
Inflammatory Bowel Disease Trial in Amsterdam (PRECISION dosing Infliximab)
Completed
- Inflammatory Bowel Disease
- PRECISION dosing Infliximab
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
Aug 2, 2019
EHR Precision Drug Treatment in Neonates
Active, not recruiting
- Pain, Acute
- Pain, Chronic
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 7, 2022
Sickle Cell Anemia in Children, Sickle Cell Disease Trial in Luanda (Hydroxyurea)
Not yet recruiting
- Sickle Cell Anemia in Children
- Sickle Cell Disease
-
Luanda, AngolaHospital Geral dos Cajueiros
Jan 26, 2023
Cesarean Section Complications, Opioid Use Trial in Pittsburgh (Preoperative Genotyping)
Recruiting
- Cesarean Section Complications
- Opioid Use
- Preoperative Genotyping
-
Pittsburgh, Pennsylvania
- +1 more
Nov 16, 2022
Lupus Nephritis Trial (Mycophenolate Mofetil)
Not yet recruiting
- Lupus Nephritis
- Mycophenolate Mofetil
- (no location specified)
Oct 20, 2021
Lupus Nephritis Trial (Mycophenolate Mofetil)
Not yet recruiting
- Lupus Nephritis
- Mycophenolate Mofetil
- (no location specified)
Sep 9, 2022
Back Pain, Leg Pain Trial in United States (Spinal Cord Stimulation)
Completed
- Back Pain
- Leg Pain
- Spinal Cord Stimulation
-
Chandler, Arizona
- +9 more
Apr 6, 2020
PPAP, Spine Fusion Trial in Pittsburgh (Preoperative Genotyping)
Recruiting
- PPAP
- Spine Fusion
- Preoperative Genotyping
-
Pittsburgh, Pennsylvania
- +1 more
Oct 7, 2022
Study of Participants Who ReceivedAllogeneic CAR T-Cell Product
Recruiting
- Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
-
Culver City, CaliforniaScience 37, Inc.
Apr 10, 2023
Precision Analgesia for Cardiac Surgery
Not yet recruiting
- Analgesia
- Cardiac Surgery
-
Pittsburgh, PennsylvaniaUPMC Presbyterian Hospital
Jan 6, 2023
Pharmacodynamics of Eculizumab in Paroxysmal Nocturnal
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- +2 more
- Blood collection for measurement of eculizumab peak concentrations
-
Nijmegen, NetherlandsRadboudumc
Aug 23, 2022
Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))
Active, not recruiting
- Tuberous Sclerosis Complex
- Epilepsy
- TAVT-18 (sirolimus)
-
Cincinnati, OhioCincinnati Children's Hospital
Jan 10, 2022